Engulfment of apoptotic Cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells

Hepatology

Volumn 45, Issue 6, 2007, Pages 1422-1432

  Wertheimer, Anne M ^a,b   Polyak, Stephen J ^c   Leistikow, Rachel ^d   Rosen, Hugo R ^d,e,f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHEMOKINE; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; INTERLEUKIN 8; STAT PROTEIN; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGEN-PRESENTING CELLS; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENETIC VECTORS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; INTERLEUKIN-8; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; PHOSPHORYLATION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TYROSINE; VACCINIA VIRUS;

EID: 34250359469     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21637     Document Type: Article

References (51)

1. Bartenschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Virol 2000;81:1631-1648.
2. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Viladomiu L, Cheung L, et al. Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Eng J Med 1996;334:1691-1696.
3. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714.
4. Perz JF, Alter MJ. The coming wave of HCV-related liver disease: dilemmas and challenges. J Hepatol 2006;44:441-443.
5. National Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Hepatitis C Fact Sheet, http://www.cdc.gov/ncidod/ diseases/hepatitis/c/fact.htm.
6. Alter HJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26(Suppl):62S-65S.
7. Valiante NM, D'Andrea A, Crotta S, Lechner F, Klenerman P, Nuti S, et al. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol Rev 2000;174:77-89.
8. Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005;175:1373-1381.
9. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
10. Ploegh HL. Viral strategies of immune evasion. Science 1998;280:248-253.
11. Lotze MT, Thomson AW, editors. Dendritic cells. San Diego: Academic Press; 2001:505-523.
12. Fugier-Vivier I, Servet-Delprat S, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. 1997. Measles virus suppresses cell-mediated immunity by interfering with the Survival and functions of dendritic and T cells. J Exp Med 1997;186:813-823.
13. Salio M, Cella M, Suter M, Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur J Immunol 1999;29:3245-3253.
14. Rescigno M, Borrow P. 2001. The host-pathogen interaction: new themes from dendritic cell biology. Cell 2001;106:267-270.
15. Fugier-Vivier I, Servet-Delprat S, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186:813-823.
16. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus infected individuals. J Immunol 1999;162:5584-5591.
17. Hiasa Y, Horiike N, Akbar SM, Saito I, Miyamura T, Matsuura Y, et al. Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C vitus genes. Biochem Biophys Res Commun 1998;249:90-95.
18. Sarobe P, Lasarte JJ, Casares N, Lopez-Diaz de Cerio A, Baixeras E, Labarga P, et al. Abnormal priming of CD4+ T cells by dendritic cells exptessing hepatitis C virus core and E1 proteins. J Virol 2002;76:5062-5070.
19. Kunitani H, Shimizu Y, Murata H, Kiyohiro H, Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 2002;36:734-741.
20. Goutagny N, Vieux C, Decullier E, Ligeoix B, Epstein A, Trepo C, et al. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis 2004;9:1646-1655.
21. Tsubouchi E, Akbar F, Horiike N, Onji M. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol 2004;39:754-762.
22. Tsubouchi E, Akbat F, Murakami H, Horiike N, Onji M. Isolation and functional analysis of circulating dendritic cells from hepatitis C vitus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol 2004;137:417-423.
23. Wertheimer AM, Bakke A, Rosen HR. 2004. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. HEPATOLOGY 2004;40:335-345.
24. Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, Cahour A. Differential distribution and internal translation efficiency of hepatitis C vitus quasi-species present in dendritic and liver cells. Blood 2003;101:52-57.
25. Wertheimer A, Miner C, Lewinsohn DM, Sasaki AW, Kaufman E, Rosen HR. Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. HEPATOLOGY 2003;37:577-589.
26. Frank I, Piatak M, Stoessel H, Romani N, Bonnyay D, Lifson J, Pope M. 2002. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs); differential intracellular fate of virions in mature and immature DCs. J Virol 2002;76:2936-2951.
27. Polyak SJ, Rawls WE, Harnish DG. Characterization of Pichinde virus infection of cells of the monocytic lineage. J Virol 1991;65:3575-3582.
28. Polyak SJ, Paschal D, McArdle S, Gale M, Moradpour D, Gretch DR. Characterization of the effects of hepatitis C virus non-structural 5A protein expression in human cell lines and on interferon-sensitive virus replication. HEPATOLOGY 1999;29:1262-1271.
29. Chaudhry A, Das SR, Hussain A, Mayor S, George A, Bal V, et al. The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 2005;175:4566-4574.
30. http://www.clontech.com/clontech/
31. Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the intefferon-induced antiviral response. J Virol 2001;75:6095-6106.
32. Girard S, Shalhoub P, Lescure P, Sabile A, Misek DE, Hanash S, et al. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 2002;295:272-283.
33. Girard S, Vossman E, Misek DE, Podevin P, Hanash S, Brechot C, Beretta L. Hepatitis C virus NS5A-regulated gene exptession and signaling revealed via microarray and comparative promoter analyses. HEPATOLOGY 2004;40:708-718.
34. Polyak SJ, Khabar KS, Rezeiq M, Gretch DR. Elevated levels of interleukin-8 in setum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol 2001;75:6209-6211.
35. Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of C4+ T cell populations lacking helper function. Nat Immunol 2005;6:163-170.
36. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-995.
37. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, Jenkins CD, MacPherson GG. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesentetic lymph nodes. J Exp Med 2000;191:435-444.
38. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106:255-258.
39. Reis e Sousa C. Dendritic cells as sensors of infection. Immunity 2001;14:495-498.
40. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. Infect Dis 2005;192:497-503.
41. Piccioli D, Tavarini S, Nuti S, Colombatto P, Brunetto M, Bonino F, et al. 2005. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J Hepatol 2005;42:61-67.
42. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics L, et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro-and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 2003;170:5615-5624.
43. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001;294:870-875.
44. Shimoda K, Gegum NA, Shibuta K, Mori M, Bonkovsky HL, Banner BF, Barnard GF. Inerleukin-8 and hIRH (SDF1-a/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. HEPATOLOGY 1998;28:108-115.
45. Kadoya H, Nagano-Fujii M, Deng L, Nakazono N, Hotta H. Nonstructural proteins 5a and 4B of hepatitis C virus transactivate the interleukin 8 promoter. Microbiol Immunol 2005;49:265-273.
46. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002:72:847-855.
47. Khabar SA, Al-Zoghaibi F, Al-Ahdal MN, Murayama T, Dhalla M, Mukaida N, et al. The alpha chemokine IL8 inhibits the antiviral action of interferon alpha. J Exp Med 1997;186:1077-1085.
48. Talavera D, Castillo A, Dominguez M, Gutierrez A, Meza I. IL8 release, tight junction and cytoskeleton dynamic reorganization conduce to permeability are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 2004;85:1801-1813.
49. Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RT. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 2005;128:1034-1041.
50. Geiss GK, Carter VS, He Y, Kwieciszewski BK, Holzman T, Korth MJ, et al. Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 2003:77:6367-6375.
51. Bartenschlager R, Lohmann V. Replication of the hepatitis C virus. Baillieres Clin Gastroenterol 2000;14:241-254.